Skip to main content
. 2013 Mar 20;304(10):R846–R853. doi: 10.1152/ajpregu.00585.2012

Fig. 2.

Fig. 2.

Semiquantitative immunoblotting analysis of CB2 in urothelium/suburothelium. Representive immunoblots are shown. The values determined by densitometry were normalized to those of GAPDH (loading control) in each sample. Exposure to acrolein for 3 h did not alter CB2 abundance in urothelium. Also, treatment with acrolein+GP1a or acrolein+AM630+GP1a did not affect abundance of CB2. n = 6 (saline-treated controls). n = 8 (other treatment groups).